RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BOSI A
Collezione AO Cuneo

Items : 10

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Falini B; Bosi A; Cortelazzo S; Audisio E; Oldani E; Spinelli O; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Scattolin AM; Todisco E; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Cavattoni I; Mattei D; Terruzzi E; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Pogliani EM; et alii...

Molecular prolife by next generation sequencing of acute myeloid leukemia with normal karyotype: Clinical results from the prospective trial 02/06 of the Northern Italy leukemia group (NILG) in Haematologica

2018
AO Cuneo
AOU Alessandria

Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

2015
AO Cuneo
AOU Alessandria

Bosi A; Bacigalupo A; Oldani E; Marfisi RM; Mordini N; Scimè R; Torelli GF; Corradini P; Alessandrino EP; Russo D; Nagler A; Marotta G; Carella AM; Arcese W; Terruzzi E; Saporiti G; Pini M; Risitano AM; Patriarca F; Guidi S; Pastore D; Chiusolo P; Raimondi R; Montanari M; Milone G; Santarone S; Cavattoni I; Busca A; Bruno B; et alii...

The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). in American journal of hematology / Am J Hematol. 2015 Jun;90(6):499-503. doi: 10.1002/ajh.23994. Epub 2015 May 10.

2015
AO Cuneo
AOU Città della Salute di Torino

Bosi A; Gotti M; Rosaria S; Maria SP; Levis A; Stefoni V; Vitolo U; Spina M; Stelitano C; Balzarotti M; Castagnoli A; Merli F; Zinzani PL; Biggi A; Rigacci L; Puccini B; Gallamini A;

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2014 Jun;20(6):872-80. doi: 10.1016/j.bbmt.2014.03.004. Epub 2014 Mar

2014
AO Cuneo
AOU Città della Salute di Torino

Locasciulli A; Rambaldi A; Bacigalupo A; Bandini G; Arcese W; Busca A; Bosi A; Majolino I; Sica S; Castagnola E; Bonini A; Olivieri A; Vallisa D; Milone G; Pisapia G; Falcioni S; Onida F; Vacca A; Pastore D; Mordini N; Russo D; Risitano AM; Prete A; Musso M; Baronciani D; Patriarca F; Irrera G; Bruno B; Zucchetti E; et alii...

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: A study from the Gruppo Italiano Trapianto di Midollo Osseo in Human Pathology

2011
AO Cuneo

Massi D; Fondi C; Nozzoli C; Benemei S; Lapi F; Albarello L; Avellini C; Bonoldi E; Casini M; Cesinaro AM; Ciceri F; Colombetti V; Comin CE; Donelli A; Fortunato M; Fratoni S; Guidi S; Messerini L; Milone G; Rapezzi D; Negri G; Patriarca F; Peccatori FA; Ponzoni M; Rafaniello P; Raimondi R; Salomone E; Tendas A; Villari L; et alii...

Imatinib is safe and effective in patients with refractory chronic graft versus host disease: Analysis of two consecutive prospective GITMO? studies. ?gruppo italiano trapianto midollo osseo in Blood

2010
AO Cuneo

Olivieri A; Cimminiello M; Locatelli F; Zecca M; Corradini P; Patriarca F; Mordini N; Iacopino P; Donelli A; Selleri C; Badiali M; Lucchini G; Gini G; Leoni P; Bosi A; Bacigalupo A;

Imatinib as salvage therapy for patients with refractory CGVHD: The interim analysis of the prospective gitmo?multicenter study?gruppo italiano trapianto di midollo osseo in Blood

2009
AO Cuneo

Olivieri A; Cimminiello M; Corradini P; Iacopino P; Donelli A; Mordini N; Selleri C; Pavone V; Fanin R; Locatelli F; Bacigalupo A; Bosi A;

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. in Haematologica / Haematologica. 2006 Apr;91(4):475-81.

2006
AO Cuneo

Levis A; Torchio P; Gregianin M; Pelosi E; Versari A; Castagnoli A; Biggi A; Tavera S; Stelitano C; Trentin L; Iannitto E; Sancetta R; Vitolo U; Luminari S; Capodanno I; Bosi A; Nassi L; Merli F; Gallamini A; Rigacci L;